|
1
|
Catalano MG, Poli R, Pugliese M, Fortunati
N and Boccuzzi G: Emerging molecular therapies of advanced thyroid
cancer. Mol Aspects Med. 31:215–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fassnacht M, Kreissl MC, Weismann D and
Allolio B: New targets and therapeutic approaches for endocrine
malignancies. Pharmacol Ther. 123:117–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patel KN and Shaha AR: Poorly
differentiated and anaplastic thyroid cancer. Cancer Control.
13:119–128. 2006.PubMed/NCBI
|
|
4
|
Sakorafas GH, Sampanis D and Safioleas M:
Cervical lymph node dissection in papillary thyroid cancer: current
trends, persisting controversies, and unclarified uncertainties.
Surg Oncol. 19:e57–e70. 2010. View Article : Google Scholar
|
|
5
|
Shimaoka K, Schoenfeld DA, DeWys WD,
Creech RH and DeConti R: A randomized trial of doxorubicin versus
doxorubicin plus cisplatin in patients with advanced thyroid
carcinoma. Cancer. 56:2155–2160. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahuja S and Ernst H: Chemotherapy of
thyroid carcinoma. J Endocrinol Invest. 10:303–310. 1987.
View Article : Google Scholar
|
|
7
|
Fleming ID, Phillips JL, Menck HR, Murphy
GP and Winchester DP: The National Cancer Data Base report on
recent hospital cancer program progress toward complete American
Joint Committee on Cancer/TNM staging. Cancer. 80:2305–2310. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Herbst RS: ZD1839: targeting the epidermal
growth factor receptor in cancer therapy. Expert Opin Investig
Drugs. 11:837–849. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bae K: The medicinal plants of Korea.
Kyo-Hak Press; Seoul: 1999
|
|
10
|
Lee HS, Beon MS and Kim MK: Selective
growth inhibitor toward human intestinal bacteria derived from
Pulsatilla cernua root. J Agric Food Chem. 49:4656–4661. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bang SC, Lee JH, Song GY, Kim DH, Yoon MY
and Ahn BZ: Antitumor activity of Pulsatilla koreana
saponins and their structure-activity relationship. Chem Pharm Bull
(Tokyo). 53:1451–1454. 2005.PubMed/NCBI
|
|
12
|
Hong SW, Jung KH, Lee HS, et al: Apoptotic
and anti-angiogenic effects of Pulsatilla koreana extract on
hepatocellular carcinoma. Int J Oncol. 40:452–460. 2012.PubMed/NCBI
|
|
13
|
Yin F, Giuliano AE and Van Herle AJ:
Growth inhibitory effects of flavonoids in human thyroid cancer
cell lines. Thyroid. 9:369–376. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cragg GM, Newman DJ and Yang SS: Natural
product extracts of plant and marine origin having antileukemia
potential. The NCI experience. J Nat Prod. 69:488–498. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O’Connor L, Huang DC, O’Reilly LA and
Strasser A: Apoptosis and cell division. Curr Opin Cell Biol.
12:257–263. 2000.
|
|
16
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krishnakumar R and Kraus WL: The PARP side
of the nucleus: molecular actions, physiological outcomes, and
clinical targets. Mol Cell. 39:8–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bolat F, Haberal N, Tunali N, Aslan E, Bal
N and Tuncer I: Expression of vascular endothelial growth factor
(VEGF), hypoxia inducible factor 1 alpha (HIF-1alpha), and
transforming growth factors beta1 (TGFbeta1) and beta3 (TGFbeta3)
in gestational trophoblastic disease. Pathol Res Pract. 206:19–23.
2010. View Article : Google Scholar
|
